Due to the opposite dopamine-adenosine functionality in the striatum, it was hypothesized that the action of dopamine in PD patients could be enhanced if the A2AR was blocked [90,91,92,93,94,95,96]. The gene discussed is ADORA2A; the disease is Parkinson disease.